News

How a Medical AI startup is stepping up the change for cancer screening

How a Medical AI startup is stepping up the change for cancer screening

Since our last edition of the 4YFN24 Awards, MICA AI has continued its growth and ambition to have a solution for the healthcare industry. We had the chance to catch up with Lior Wayn, CEO and Co-founder and find out more about what their next steps are...

Congratulations on being one of our 4YFN24 finalists! What was a pivotal moment at 4YFN24 that deeply influenced your startup's direction? How did this experience shape your future or strategies?

MICA AI  has presented at the 2024 4YFN Award main stage of the future of breast cancer screening - a GenAI platform that supports the doctor's decision, increases the accuracy rate and precision and reduces double radiation, invasive procedures, pain, time and money. After the presentation, I met a lot of people (men and women) who told me how that touched them because of various reasons... And how important is to bring MICA's innovative solutions to the clinicians. This experience strengthened my understanding about 4YFN - 4 Years From Now MICA will be the standard of care for so many women around the globe!

 

4YFN24 was rich with opportunities for innovation and networking. Can you share a connection or partnership formed at the event that has been particularly impactful for your startup? How has this relationship contributed to your progress?

I met a lot of interesting people at the 4YFN from the technological, business and medical arenas. One of them, is a medical regulatory expert, and I plan to work together in submitting to the CE MDR certification in Europe.

 

Being a finalist at 4YFN24 is a noteworthy milestone. How has your participation at 4YFN24 enhanced your startup’s visibility, recognition, or access to resources? What strategies would you recommend to future finalists to make the most out of their experience?

First, this is a great honour to be a finalist, pitch on the stage and meet so many market leaders. Also, the video of the pitch and the publication of case study at the GSMA network increased the visibility of MICA at the social network.
I will suggest to future finalists to enjoy the process, walk from hall to hall and meet exhibitors and participants, since there are 10s of thousands of people there, so look for your 1% of opportunity!

 

Reflecting on your experience at 4YFN24, what were the most significant learnings or insights you gained? How have these insights influenced your approach to innovation and growth in the startup ecosystem?

I will say that the understanding that we are not alone... I mean, that startups all over the world, in any arena of activity and in any size, are struggling with challenges. So if you understand that those are challenges and not problems, you are in the halfway to finding the solution


 

Curious to know more about MICA and the work they are doing battling breast cancer with Gen AI? Read the full case study published by the GSMA Foundry here.

 

The applications for the prestigious 4YFN25 Awards are now closed. Stay tuned to find out which companies will become finalists and which will have the chance of receiving a €20,000 cash prize, along with numerous other benefits designed to accelerate their business growth and visibility. For more information, see more here.